| Title |
Vinpocetine for cognitive impairment and dementia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, January 2003
|
| DOI | 10.1002/14651858.cd003119 |
| Pubmed ID | |
| Authors |
Szabolcs Szatmári, Peter Whitehouse |
| Abstract |
Vinpocetine is a synthetic ethyl ester of apovincamine, a vinca alkaloid obtained from the leaves of the Lesser Periwinkle (Vinca minor) and discovered in the late 1960s. Although used in human treatment for over twenty years, it has not been approved by any regulatory body for the treatment of cognitive impairment. Basic sciences studies have been used to claim a variety of potentially important effects in the brain. However, despite these many proposed mechanisms and targets, the relevance of this basic science to clinical studies is unclear. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 176 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| United Kingdom | 1 | <1% |
| Unknown | 173 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 23 | 13% |
| Researcher | 22 | 13% |
| Student > Master | 18 | 10% |
| Student > Ph. D. Student | 13 | 7% |
| Other | 9 | 5% |
| Other | 27 | 15% |
| Unknown | 64 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 15% |
| Agricultural and Biological Sciences | 16 | 9% |
| Nursing and Health Professions | 10 | 6% |
| Psychology | 10 | 6% |
| Biochemistry, Genetics and Molecular Biology | 8 | 5% |
| Other | 34 | 19% |
| Unknown | 71 | 40% |
Attention Score in Context
This research output has an Altmetric Attention Score of 131. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 April 2024.
All research outputs
#322,756
of 25,712,965 outputs
Outputs from Cochrane database of systematic reviews
#537
of 13,134 outputs
Outputs of similar age
#422
of 139,375 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 55 outputs
Altmetric has tracked 25,712,965 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,134 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,375 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 55 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.